Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways

Nonresolving Inflammation in gp91phox-/- Mice, a Model of Human Chronic Granulomatous Disease, Has Lower Adenosine and Cyclic Adenosine 5'-Monophosphate

(2009) R. Rajakariar et al.   JOURNAL OF IMMUNOLOGY

Effects of Low-Dose Aspirin on Acute Inflammatory Responses in Humans

(2009) T. Morris et al.   JOURNAL OF IMMUNOLOGY

Lipoxin A4: Anti-Inflammatory and Anti-Angiogenic Impact on Endothelial Cells

(2009) N. Baker et al.   JOURNAL OF IMMUNOLOGY

Famotidine for the prevention of peptic ulcers and oesophagitis in patients taking low-dose aspirin (FAMOUS): a phase III, randomised, double-blind, placebo-controlled trial

(2009) Ali S Taha et al.   LANCET

Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis

(2009) Matthew Spite et al.   NATURE

Inverse temporal changes of lipoxin A4 and leukotrienes in children with Henoch–Schönlein purpura

(2009) Sheng-Hua Wu et al.   PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS

Novel biphasic role for lymphocytes revealed during resolving inflammation

(2008) R. Rajakariar et al.   BLOOD

Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP

(2008) J. Bystrom et al.   BLOOD

2-Diethylaminoethyl-2,2-diphenylvalerate-HCl (SKF525A) Revisited: Comparative Cytochrome P450 Inhibition in Human Liver Microsomes by SKF525A, Its Metabolites, and SKF-Acid and SKF-Alcohol

(2008) M. R. Franklin et al.   DRUG METABOLISM AND DISPOSITION

A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis

(2008) Y Fang et al.   JOURNAL OF PATHOLOGY

Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation

(2008) John M. Hallett et al.   TRENDS IN PHARMACOLOGICAL SCIENCES